Clinical Trial Detail

NCT ID NCT02706392
Title Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

triple-receptor negative breast cancer

chronic lymphocytic leukemia

acute lymphoblastic leukemia

lung non-small cell carcinoma

mantle cell lymphoma

Therapies

Cyclophosphamide + Fludarabine + ROR1 CAR-T cells

Age Groups: adult senior

No variant requirements are available.